Replimune Group, Inc. Profile Avatar - Palmy Investing

Replimune Group, Inc.

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against canc…

Biotechnology
US, Woburn [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Replimune Group, Inc. (REPL) to it's peer group.

Peer Group
CERE NUVL UTHR CRNX AVTE KURA KRON VTYX PRTC GOSS SNDX PTGX MLYS KROS NVCT LYRA Compare Together
Loading...
End of REPL's Analysis
CIK: 1737953 CUSIP: 76029N106 ISIN: US76029N1063 LEI: - UEI: -
Secondary Listings
REPL has no secondary listings inside our databases.